Article citationsMore>>
Tan, B.J., Sugata, K., Reda, O., Matsuo, M., Uchiyama, K., Miyazato, P., Hahaut, V., Yamagishi, M., Uchimaru, K., Suzuki, Y., Ueno, T., Suzushima, H., Katsuya, H., Tokunaga, M., Uchiyama, Y., Nakamura, H., Sueoka, E., Utsunomiya, A., Ono, M. and Satou, Y. (2021) HTLV-1 Infection Promotes Excessive T Cell Activation and Transformation into Adult T Cell Leukemia/Lymphoma. The Journal of Clinical Investigation, 131, e50472.
https://doi.org/10.1172/JCI150472
has been cited by the following article:
-
TITLE:
Damage Mechanism of CK2 and IKAROS in Philadelphia Like Acute Lymphoblastic Leukemia
AUTHORS:
Ignacio Vélez-Rodríguez, Victoria Carranza-Aranda
KEYWORDS:
Acute Lymphoblastic Leukemia, IKAROS, Dephosphorylation, Philadelphia Chromosome, CK2
JOURNAL NAME:
Journal of Biosciences and Medicines,
Vol.12 No.4,
April
10,
2024
ABSTRACT: Acute lymphoblastic leukemia (ALL) is characterized by immature and poorly differentiated B lymphocytes in large numbers in the blood. B cells are distinct from the cell types involved in their development (common lymphoid progenitor cells, pro-B cells, pre-B cells, and mature cells). The process of B cell maturation depends on precise communication within the cell: signals activate specific genes that are essential for proper development. Errors in this intricate signaling network can lead to issues with B cell function and contribute to disease. B-lineage acute lymphoid leukemias, malignancies of precursor-stage B lymphoid cells inhibit lymphoid differentiation, leading to abnormal cell proliferation and survival. The process of developing leukemia (leukemogenesis) can be triggered by an overproduction of both hematopoietic stem cells (the cells that form all blood cells) and the immature versions of white blood cells called lymphoblasts. Acute lymphoblastic leukemia (ALL) with the presence of the Philadelphia chromosome (ALL Ph) is classified as a high-risk manifestation of the disease, this chromosome is the product of the reciprocal translocation, whose product is a BCR-ABL fusion protein. It is a highly active tyrosine kinase that can transform hematopoietic cells into cytokine-independent. Hyperphosphorylation cascades inhibit the differentiating function of IKZF1 as a tumor suppressor gene which leads to an abnormal proliferation of B cells due to the presence of the Philadelphia chromosome; it inhibits the differentiating process, leukemogenesis involving immature B cells in the bloodstream can result from the uncontrolled growth and division of hematopoietic stem cells and immature lymphoblasts (the precursors to B cells).
Related Articles:
-
Monji Koga, Masaki Fujita, Shinichi Imafuku
-
R. Douglas Martin, Shengyu Zhang
-
Daoling Fu, Ming Yang, Jindong Chang
-
Sayeedeh Abdollahi, Mohammad Reza Salehi Rad
-
Pascal Diogène Bingui Outman, Nelly Sandrine Guembo Pandzou, Rolyne Vanissia Madzou Nganie, Verlem Bomelefa-Bomel, Benoite Diatewa, Kadidja Grace Nkounkou Milandou, Jean Brice Mouendenguia, Luopou Lamah, Audrey Niangui-Bakala, Dorthéa Banga Massalat, Rel Gérald Boukaka Kala, Jean Robert Mabiala Babela